164 related articles for article (PubMed ID: 37820443)
1. Triglyceride content increases while cholesterol content decreases in HDL and LDL+IDL fractions following normal meals: The Copenhagen General Population Study of 25,656 individuals.
Johansen MØ; Moreno-Vedia J; Balling M; Davey Smith G; Nordestgaard BG
Atherosclerosis; 2023 Oct; 383():117316. PubMed ID: 37820443
[TBL] [Abstract][Full Text] [Related]
2. Plasma lipoprotein subclass variation in middle-aged and older adults: Sex-stratified distributions and associations with health status and cardiometabolic risk factors.
Masuda R; Wist J; Lodge S; Kimhofer T; Hunter M; Hui J; Beilby JP; Burnett JR; Dwivedi G; Schlaich MP; Bong SH; Loo RL; Holmes E; Nicholson JK; Yeap BB
J Clin Lipidol; 2023; 17(5):677-687. PubMed ID: 37442713
[TBL] [Abstract][Full Text] [Related]
3. Role of hepatic lipase in intermediate-density lipoprotein and small, dense low-density lipoprotein formation in hemodialysis patients.
Oi K; Hirano T; Sakai S; Kawaguchi Y; Hosoya T
Kidney Int Suppl; 1999 Jul; 71():S227-8. PubMed ID: 10412783
[TBL] [Abstract][Full Text] [Related]
4. Distribution of lipoproteins triglyceride and lipoprotein cholesterol in an adult population by age, sex, and hormone use- The Pacific Northwest Bell Telephone Company health survey.
Wahl PW; Warnick GR; Albers JJ; Hoover JJ; Walden CE; Bergelin RO; Ogilvie JT; Hazzard WR; Knopp RH
Atherosclerosis; 1981 Apr; 39(1):111-24. PubMed ID: 6941788
[TBL] [Abstract][Full Text] [Related]
5. Lipoprotein subfraction changes in normal pregnancy: threshold effect of plasma triglyceride on appearance of small, dense low density lipoprotein.
Sattar N; Greer IA; Louden J; Lindsay G; McConnell M; Shepherd J; Packard CJ
J Clin Endocrinol Metab; 1997 Aug; 82(8):2483-91. PubMed ID: 9253322
[TBL] [Abstract][Full Text] [Related]
6. An increased number of very-low-density lipoprotein particles is strongly associated with coronary heart disease in Japanese men, independently of intermediate-density lipoprotein or low-density lipoprotein.
Koba S; Hirano T; Sakaue T; Takeuchi H; Adachi M; Katagiri T
Coron Artery Dis; 2002 Aug; 13(5):255-62. PubMed ID: 12394649
[TBL] [Abstract][Full Text] [Related]
7. Hyperapobetalipoproteinemia with compositional abnormality of LDL and IDL, a characteristic lipoprotein alteration in essential hypertension.
Ryomoto KI; Suzuki M; Kanazawa A; Hasegawa M; Kimura Y; Yamamura T; Harano Y
Am J Hypertens; 2000 Jun; 13(6 Pt 1):617-24. PubMed ID: 10912744
[TBL] [Abstract][Full Text] [Related]
8. Effects of fenofibrate and ezetimibe, both as monotherapy and in coadministration, on cholesterol mass within lipoprotein subfractions and low-density lipoprotein peak particle size in patients with mixed hyperlipidemia.
Tribble DL; Farnier M; Macdonell G; Perevozskaya I; Davies MJ; Gumbiner B; Musliner TA
Metabolism; 2008 Jun; 57(6):796-801. PubMed ID: 18502262
[TBL] [Abstract][Full Text] [Related]
9. Intermediate density lipoprotein levels are strong predictors of the extent of aortic atherosclerosis in the St. Thomas's Hospital rabbit strain.
Nordestgaard BG; Lewis B
Atherosclerosis; 1991 Mar; 87(1):39-46. PubMed ID: 1872923
[TBL] [Abstract][Full Text] [Related]
10. Apolipoprotein E2 reduces the low density lipoprotein level in transgenic mice by impairing lipoprotein lipase-mediated lipolysis of triglyceride-rich lipoproteins.
Huang Y; Liu XQ; Rall SC; Mahley RW
J Biol Chem; 1998 Jul; 273(28):17483-90. PubMed ID: 9651338
[TBL] [Abstract][Full Text] [Related]
11. Preferential reduction of very low density lipoprotein-1 particle number by fenofibrate in type IIB hyperlipidemia: consequences for lipid accumulation in human monocyte-derived macrophages.
Milosavljevic D; Griglio S; Le Naour G; Chapman MJ
Atherosclerosis; 2001 Mar; 155(1):251-60. PubMed ID: 11223449
[TBL] [Abstract][Full Text] [Related]
12. Heterogeneous properties of intermediate- and low-density lipoprotein subpopulations.
Srisawasdi P; Vanavanan S; Rochanawutanon M; Pornsuriyasak P; Tantrakul V; Kruthkul K; Kotani K
Clin Biochem; 2013 Oct; 46(15):1509-15. PubMed ID: 23830843
[TBL] [Abstract][Full Text] [Related]
13. A third of nonfasting plasma cholesterol is in remnant lipoproteins: Lipoprotein subclass profiling in 9293 individuals.
Balling M; Langsted A; Afzal S; Varbo A; Davey Smith G; Nordestgaard BG
Atherosclerosis; 2019 Jul; 286():97-104. PubMed ID: 31108411
[TBL] [Abstract][Full Text] [Related]
14. Dose-dependent action of atorvastatin in type IIB hyperlipidemia: preferential and progressive reduction of atherogenic apoB-containing lipoprotein subclasses (VLDL-2, IDL, small dense LDL) and stimulation of cellular cholesterol efflux.
Guerin M; Egger P; Soudant C; Le Goff W; van Tol A; Dupuis R; Chapman MJ
Atherosclerosis; 2002 Aug; 163(2):287-96. PubMed ID: 12052475
[TBL] [Abstract][Full Text] [Related]
15. High-fat meal effect on LDL, HDL, and VLDL particle size and number in the Genetics of Lipid-Lowering Drugs and Diet Network (GOLDN): an interventional study.
Wojczynski MK; Glasser SP; Oberman A; Kabagambe EK; Hopkins PN; Tsai MY; Straka RJ; Ordovas JM; Arnett DK
Lipids Health Dis; 2011 Oct; 10():181. PubMed ID: 22008512
[TBL] [Abstract][Full Text] [Related]
16. Quantification of lipoprotein subclasses by proton nuclear magnetic resonance-based partial least-squares regression models.
Petersen M; Dyrby M; Toubro S; Engelsen SB; Nørgaard L; Pedersen HT; Dyerberg J
Clin Chem; 2005 Aug; 51(8):1457-61. PubMed ID: 15961551
[TBL] [Abstract][Full Text] [Related]
17. Quantitative NMR-Based Lipoprotein Analysis Identifies Elevated HDL-4 and Triglycerides in the Serum of Alzheimer's Disease Patients.
Berezhnoy G; Laske C; Trautwein C
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293327
[TBL] [Abstract][Full Text] [Related]
18. Atherogenic lipoprotein changes in the absence of hyperlipidemia in patients with chronic renal failure treated by hemodialysis.
Shoji T; Nishizawa Y; Kawagishi T; Tanaka M; Kawasaki K; Tabata T; Inoue T; Morii H
Atherosclerosis; 1997 Jun; 131(2):229-36. PubMed ID: 9199276
[TBL] [Abstract][Full Text] [Related]
19. Glibenclamide improves postprandial hypertriglyceridaemia in type 2 diabetic patients by reducing chylomicrons but not the very low-density lipoprotein subfraction levels.
Skrapari I; Perrea D; Ioannidis I; Karabina SA; Elisaf M; Tselepis AD; Karagiannacos P; Katsilambros N
Diabet Med; 2001 Oct; 18(10):781-5. PubMed ID: 11678967
[TBL] [Abstract][Full Text] [Related]
20. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
